| SKU | Size | Availability | Price | Qty |
|---|---|---|---|---|
| P475624-1g | 1g | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $643.90 |
| Specifications & Purity | PEG average Mₙ 5,000, PLGA Mₙ 10,000, lactide:glycolide 50:50 |
|---|---|
| Storage Temp | Store at -20°C |
| Shipped In | Ice chest + Ice pads |
| Product Description | Description Contains ≤500 ppm impurities by GC, including trace monomer and residual organics.Biocompatible block copolymer. Can be used in the formation of nanoparticles for drug delivery. Potenial use in the targeted and/or controlled release of cancer drugs, anti-inflammatory drugs, antibiotics, or anesthetic agents. |
Enter Lot Number to search for COA:
| 1. Yihan Xu, Chang-Soo Kim, David M Saylor, Donghun Koo,. (2016-04-22) Polymer degradation and drug delivery in PLGA-based drug-polymer applications: A review of experiments and theories.. Journal of biomedical materials research. Part B, Applied biomaterials, 105 ((6)): ( 1692-1716 ). [PMID:27098357] |
